VRTX - Company ID 0000875320
The table below shows VERTEX PHARMACEUTICALS INC / MA's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.49B | $4.94B | $4.97B | $4.67B | $5.24B | $4.58B |
| Short-term investments | $1.75B | $1.35B | $1.41B | $1.53B | $1.29B | $1.22B |
| Receivables | $2.00B | $1.95B | $1.89B | $1.81B | $1.75B | $1.66B |
| Inventory | $1.77B | $1.63B | $1.50B | $1.36B | $1.08B | $914.60M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $11.73B |
| $10.57B |
| $10.43B |
| $10.01B |
| $9.80B |
| $8.94B |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B |
| Total assets | $26.48B | $24.86B | $24.04B | $22.88B | $22.24B | $20.13B |
| Accounts payable | $489.30M | $420.30M | $442.30M | $445.00M | $395.80M | $327.90M |
| Total current liabilities | $3.88B | $4.48B | $4.14B | $3.78B | $3.97B | $3.55B |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $7.12B | $7.54B | $6.86B | $6.38B | $6.61B | $5.36B |
| Retained earnings | $14.59B | $12.37B | $11.29B | $10.25B | $8.69B | $7.65B |
| Total equity | $19.36B | $17.32B | $17.18B | $16.50B | $15.63B | $14.77B |